HSIE Results Daily: Sun Pharma, Shriram Transport Finance, JK Lakshmi Cement
Sun Pharma: Suns Q1 revenue/EBITDA grew by 28%/55% YoY, led by robust growth across markets and restricted spends driving sharp operating leverage...
131 Views
Sun Pharmaceutical Industries: Strong Q1 Beat on All Fronts but Upside Capped
In the US, Sun diversifying into specialty products like Ilumya, Levulan, BromSite, Cequa, Xelpros, Odomzo, Yonsa, winlwvi etc. Key Risk: (i) Price...
133 Views
HSIE Results Daily: Sun Pharma, Bharat Petroleum Corporation, Eicher Motors, Cadila Healthcare, V...
V-Guard Industries: V-Guard posted in-line but strong revenue growth of 58% YoY (HSIE 59%), clocking 2-year revenue CAGR of 7%. South region posted...
172 Views
Domestic Formulation on steady footing
Sun Pharma (SUNP) delivered a 4QFY21 performance marginally below our expectations, weighed by moderation in US and API sales. Domestic Formulation...
265 Views
Pakistan Market Outlook 2017
Pakistan market is expected to continue its uptrend in 2017 given tangible gains from China Pakistan Economic Corridor (CPEC) projects and rising...
383 Views